Skip to main content
E

EUROFARMA LABORATÓRIOS S.A. — Investor Relations & Filings

LEI · 254900GA8883LV1TXY07 SA Manufacturing
Open in API
Filings indexed 46 across all filing types
Latest filing 2026-04-22 Notice of Dividend Amou…
Country BR Brazil
Listing SA

About EUROFARMA LABORATÓRIOS S.A.

Eurofarma Laboratórios S.A. is a multinational organization established in 1972, specializing in the research, development, manufacturing, and commercialization of medicinal products. The company maintains a diverse portfolio encompassing prescription drugs, generics, oncology treatments, and veterinary medicines. It covers over 200 therapeutic classes and serves all major medical specialties, offering a catalog of more than 430 products. Operating through an extensive network of manufacturing facilities, the organization focuses on technological innovation and the production of complex therapeutic solutions. Its operations span across various international markets, supported by a robust infrastructure designed to meet broad medical needs and ensure the strategic distribution of its product lines.

Recent filings

Filing Released Lang Actions
Pagamento de proventos
Notice of Dividend Amount Classification · 1% confidence The document is a market communication announcing payment of dividends and interest on equity (JCP) with detailed payment schedule and amounts. This fits the “Notice of Dividend Amount” category (DIV).
2026-04-22 Portuguese
-
Director's Dealing Classification · 1% confidence The document is a Formulário Consolidado titled “Negociação de Administradores e Pessoas Ligadas,” listing share positions and confirming that no insider transactions occurred for directors and related persons in March 2026. This matches the definition of a Director’s Dealing report (insider share transaction disclosure).
2026-04-06 Portuguese
-
Transaction in Own Shares Classification · 1% confidence The document is a Brazilian CVM “Formulário Individual” disclosing the company’s own securities trading (“Negociação de Valores Mobiliários pela própria companhia, suas controladas e coligadas”) and shows that no share/derivative operations occurred but lists the company’s positions. This matches a report of transactions in the company’s own shares. Therefore, it should be classified as Transaction in Own Shares (POS).
2026-04-06 Portuguese
DFP 2025
Regulatory Filings
2026-03-26 Portuguese
ITR 2025-Q3
Regulatory Filings
2025-11-14 Portuguese
ITR 2025-Q1 v2
Regulatory Filings
2025-09-01 Portuguese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.